Analysts Anticipate Balchem Co. (NASDAQ:BCPC) to Post $0.84 EPS

Brokerages expect Balchem Co. (NASDAQ:BCPC) to announce earnings per share (EPS) of $0.84 for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Balchem’s earnings. Balchem posted earnings of $0.77 per share in the same quarter last year, which suggests a positive year over year growth rate of 9.1%. The business is expected to issue its next quarterly earnings report on Thursday, February 27th.

According to Zacks, analysts expect that Balchem will report full-year earnings of $3.16 per share for the current year. For the next fiscal year, analysts forecast that the firm will post earnings of $3.17 per share, with EPS estimates ranging from $3.07 to $3.27. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side analysts that cover Balchem.

Balchem (NASDAQ:BCPC) last posted its earnings results on Tuesday, November 5th. The basic materials company reported $0.81 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.74 by $0.07. Balchem had a return on equity of 14.01% and a net margin of 12.43%. The company had revenue of $158.60 million for the quarter, compared to analyst estimates of $166.42 million. During the same quarter last year, the company earned $0.73 earnings per share. The company’s revenue for the quarter was up 2.3% on a year-over-year basis.

A number of brokerages recently commented on BCPC. BidaskClub downgraded Balchem from a “hold” rating to a “sell” rating in a research report on Thursday, November 21st. ValuEngine downgraded Balchem from a “hold” rating to a “sell” rating in a research report on Wednesday, December 4th. Zacks Investment Research downgraded Balchem from a “hold” rating to a “strong sell” rating in a research report on Thursday, November 7th. Finally, HC Wainwright reaffirmed a “positive” rating and set a $110.00 price target (up from $95.00) on shares of Balchem in a research report on Wednesday, November 6th. Three research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $107.67.

Several institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. increased its position in shares of Balchem by 1.0% during the second quarter. BlackRock Inc. now owns 4,712,524 shares of the basic materials company’s stock valued at $471,110,000 after acquiring an additional 47,908 shares during the last quarter. Wasatch Advisors Inc. increased its position in Balchem by 6.0% in the second quarter. Wasatch Advisors Inc. now owns 1,306,898 shares of the basic materials company’s stock worth $130,651,000 after buying an additional 74,061 shares during the last quarter. Conestoga Capital Advisors LLC increased its position in Balchem by 2.6% in the second quarter. Conestoga Capital Advisors LLC now owns 822,800 shares of the basic materials company’s stock worth $82,255,000 after buying an additional 20,812 shares during the last quarter. Northern Trust Corp increased its position in Balchem by 1.0% in the second quarter. Northern Trust Corp now owns 478,505 shares of the basic materials company’s stock worth $47,837,000 after buying an additional 4,940 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its position in Balchem by 0.8% in the second quarter. Bank of New York Mellon Corp now owns 433,039 shares of the basic materials company’s stock worth $43,290,000 after buying an additional 3,229 shares during the last quarter. 88.01% of the stock is owned by institutional investors.

Shares of BCPC traded up $0.78 on Thursday, reaching $101.73. 2,630 shares of the company’s stock traded hands, compared to its average volume of 95,904. The company has a current ratio of 3.33, a quick ratio of 2.31 and a debt-to-equity ratio of 0.32. The stock has a market cap of $3.30 billion, a PE ratio of 33.83 and a beta of 1.18. The stock’s 50 day simple moving average is $101.12 and its two-hundred day simple moving average is $97.20. Balchem has a 52-week low of $73.16 and a 52-week high of $106.56.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.

Read More: Depreciation

Get a free copy of the Zacks research report on Balchem (BCPC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.